These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 13518848)

  • 21. The influence of intrinsic coagulation pathway on blood platelets activation by oxidized cellulose.
    Krízová P; Másová L; Suttnar J; Salaj P; Dyr JE; Homola J; Pecka M
    J Biomed Mater Res A; 2007 Aug; 82(2):274-80. PubMed ID: 17274026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of etamsylate on equine platelets: in vitro and in vivo studies.
    Segura D; Monreal L; Pérez-Pujol S; Alonso A; Díaz-Ricart M; Brugués R; Ordinas A; Escolar G
    Vet J; 2007 Sep; 174(2):325-9. PubMed ID: 16904352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution.
    Dohan DM; Choukroun J; Diss A; Dohan SL; Dohan AJ; Mouhyi J; Gogly B
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Mar; 101(3):e37-44. PubMed ID: 16504849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The contribution of platelets in the production of cryoprecipitates for use in a fibrin glue.
    Rock G; Neurath D; Lu M; Alharbi A; Freedman M
    Vox Sang; 2006 Oct; 91(3):252-5. PubMed ID: 16958838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet-rich and platelet-poor plasma: development of an animal model to evaluate hemostatic efficacy.
    Pietrzak WS; An YH; Kang QK; Demos HA; Ehrens KH
    J Craniofac Surg; 2007 May; 18(3):559-67. PubMed ID: 17538318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Presence in erythrocytes of thromboplastic components].
    BALUDA VP
    Biull Eksp Biol Med; 1957 Sep; 44(9):7-9. PubMed ID: 13499522
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical study of a thromboplastic type hemostatic].
    CABRAL JM
    Port Med; 1959 Jan; 43(1):14-20. PubMed ID: 13645289
    [No Abstract]   [Full Text] [Related]  

  • 28. Progress with pathogen-reduced blood.
    McCullough J
    Blood; 2018 Jul; 132(2):119-121. PubMed ID: 30002047
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of desmopressin (DDAVP) on platelet membrane glycoprotein expression in patients with von Willebrand's disease.
    Gordz S; Mrowietz C; Pindur G; Park JW; Jung F
    Clin Hemorheol Microcirc; 2005; 32(2):83-7. PubMed ID: 15764817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry.
    Giannini S; Mezzasoma AM; Leone M; Gresele P
    Haematologica; 2007 Dec; 92(12):1647-54. PubMed ID: 18055988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stability of an autologous platelet clot in the pericardial sac: An experimental and clinical study.
    Rademakers LM; Gründeman PF; Bolderman RW; van der Veen FH; Maessen JG
    J Thorac Cardiovasc Surg; 2009 May; 137(5):1190-4. PubMed ID: 19379990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet gel and fibrin sealant reduce allogeneic blood transfusions in total knee arthroplasty.
    Everts PA; Devilee RJ; Brown Mahoney C; Eeftinck-Schattenkerk M; Box HA; Knape JT; van Zundert A
    Acta Anaesthesiol Scand; 2006 May; 50(5):593-9. PubMed ID: 16643230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet nitric oxide synthase is activated by tyrosine dephosphorylation: possible role for SHP-1 phosphatase.
    Patel B; Sharifi M; Milward AD; Oberprieler NG; Gibbins JM; Parkin S; Naseem KM
    J Thromb Haemost; 2006 Nov; 4(11):2423-32. PubMed ID: 16898954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haemostatic effects of polymerized albumin particles carrying fibrinogen gamma-chain dodecapeptide as platelet substitutes in severely thrombocytopenic rabbits.
    Okamura Y; Fujie T; Nogawa M; Maruyama H; Handa M; Ikeda Y; Takeoka S
    Transfus Med; 2008 Jun; 18(3):158-66. PubMed ID: 18598278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The mechanism of alphaIIbbeta3 antagonism by savignygrin and its implications for the evolution of anti-hemostatic strategies in soft ticks.
    Mans BJ; Neitz AW
    Insect Biochem Mol Biol; 2004 Jun; 34(6):573-84. PubMed ID: 15147758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part V: histologic evaluations of PRF effects on bone allograft maturation in sinus lift.
    Choukroun J; Diss A; Simonpieri A; Girard MO; Schoeffler C; Dohan SL; Dohan AJ; Mouhyi J; Dohan DM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Mar; 101(3):299-303. PubMed ID: 16504861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered calcium signalling in platelets from bile-duct-ligated rats.
    Atucha NM; Iyú D; Alcaraz A; Rosa V; Martínez-Prieto C; Ortiz MC; Rosado JA; García-Estañ J
    Clin Sci (Lond); 2007 Feb; 112(3):167-74. PubMed ID: 16948638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retention test Homburg to monitor the adhesive properties of von Willebrand factor after substitution or desmopressin therapy.
    Wieding JU; Matern J; Köstering H; Wermes C; Wenzel E
    Semin Thromb Hemost; 2005; 31(4):441-8. PubMed ID: 16149022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel modification of the Thrombelastograph assay, isolating platelet function, correlates with optical platelet aggregation.
    Craft RM; Chavez JJ; Bresee SJ; Wortham DC; Cohen E; Carroll RC
    J Lab Clin Med; 2004 May; 143(5):301-9. PubMed ID: 15122174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of physiologic shear stresses and calcium on agonist-induced platelet aggregation, secretion, and thromboxane A2 formation.
    Viisoreanu D; Gear A
    Thromb Res; 2007; 120(6):885-92. PubMed ID: 17306868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.